Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Antimicrobial Resistance & Infection Control
Published in: Antimicrobial Resistance & Infection Control 1/2016

Open Access 01-12-2016 | Review

APSIC guide for prevention of Central Line Associated Bloodstream Infections (CLABSI)

Authors: Moi Lin Ling, Anucha Apisarnthanarak, Namita Jaggi, Glenys Harrington, Keita Morikane, Le Thi Anh Thu, Patricia Ching, Victoria Villanueva, Zhiyong Zong, Jae Sim Jeong, Chun-Ming Lee

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2016

Login to get access

Abstract

This document is an executive summary of the APSIC Guide for Prevention of Central Line Associated Bloodstream Infections (CLABSI). It describes key evidence-based care components of the Central Line Insertion and Maintenance Bundles and its implementation using the quality improvement methodology, namely the Plan-Do-Study-Act (PDSA) methodology involving multidisciplinary process and stakeholders. Monitoring of improvement over time with timely feedback to stakeholders is a key component to ensure the success of implementing best practices. A surveillance program is recommended to monitor outcomes and adherence to evidence-based central line insertion and maintenance practices (compliance rate) and identify quality improvement opportunities and strategically targeting interventions for the reduction of CLABSI.
Literature
1.
The Joint Commission. Preventing Central Line–Associated Bloodstream Infections: A Global Challenge, a Global Perspective. Oak Brook: Joint Commission Resources; 2012.
2.
Pronovost P, Needham D, Berenholtz S, Frank J, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725–32.CrossRefPubMed
3.
Datta P, Rani H, Chauhan R, Gombar S, Chander J. Health-care-associated infections: Risk factors and epidemiology from an intensive care unit in Northern India. Indian J Anaesth. 2014;58(1):30–5.CrossRefPubMedPubMedCentral
4.
Fraenkel D, Rickard C, Thomas P, Faoagali J, George N, Ware R. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. Crit Care Med. 2006;34(3):668–75.CrossRefPubMed
5.
Kim SH, Song KI, Chang JW, Kim SB, Sung SA, Jo SK, et al. Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomized clinical trial. Kidney Int. 2006;69(1):161–4.CrossRefPubMed
6.
Richards B, Chaboyer W, Bladen T, Schluter PJ. Effect of central venous catheter type on infections: a prospective clinical trial. J Hosp Infect. 2003;54(1):10–7.CrossRefPubMed
7.
Sheng WH, Ko WJ, Wang JT, Chang SC, Hsueh PR, Luh KT. Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients. Diagn Microbiol Infect Dis. 2000;38(1):1–5.CrossRefPubMed
8.
Yoshida J, Ishimaru T, Fujimoto M, Hirata N, Matsubara N, Koyanagi N. Risk factors for central venous catheter-related bloodstream infection: a 1073-patient study. J Infect Chemother. 2008;14(6):399–403.CrossRefPubMed
9.
Zhang P, Yuan J, Tan H, Lv R, Chen J. Successful prevention of cuffed hemodialysis catheter-related infection using an antibiotic lock technique by strictly catheter-restricted antibiotic lock solution method. Blood Purif. 2009;27(2):206–11.CrossRefPubMed
10.
Apisarnthanarak A, Greene MT, Kennedy EH, Khawcharoenporn T, Krein S, Saint S. National survey of practices to prevent healthcare-associated infections in Thailand: the role of safety culture and collaboratives. Infect Control Hosp Epidemiol. 2012;33(7):711–7. doi:10.​1086/​666330. Epub 2012 May 14.CrossRefPubMed
11.
12.
13.
Jaggi N, Rodrigues C, Rosenthal VD, Todi SK, Shah S, Saini N, et al. Impact of an International Nosocomial Infection Control Consortium multidimensional approach on central line-associated bloodstream infection rates in adult intensive care units in eight cities in India. Int J Infect Dis. 2013;17(12):1218–24.CrossRef
14.
Jaggi N, Nirwan P, Naryana E, Kaur KP. The analysis and impact of three successive intervention programmes directed to reduce central line associated blood stream infections over a four year period in a tertiary care hospital in India. Antimicrobial Resistance and Infection Control. 2013;2 Suppl 1:2. doi:10.​1186/​2047-2994-2-S1-P2.CrossRef
15.
16.
Parienti JJ, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA. 2008;299:2413–22.CrossRefPubMed
17.
Nagashima G, Kikuchi T, Tsuyuzaki H, et al. To reduce catheter-related bloodstream infections: is the subclavian route better than the jugular route for central venous catheterization? J Infect Chemother. 2006;12:363–5.CrossRefPubMed
18.
19.
Larson EL, Rackoff WR, Weiman M, et al. APIC guideline for handwashing and hand antisepsis in health care settings. Am J Infect Control. 1995;23:251–69.CrossRefPubMed
20.
WHO Guidelines on Hand Hygiene in Health Care: a Summary 2009.
21.
Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338:339–43.CrossRefPubMed
22.
Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med. 2002;136:792–801.CrossRefPubMed
23.
Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol. 1994;15:231–8.CrossRefPubMed
24.
Lin TY, Lee CM, Wang FD, et al. Taiwan guidelines for prevention and control of intravascular catheter-related bloodstream infections. 2011.
25.
O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162-93. doi:10.​1093/​cid/​cir257.
26.
27.
Guide to the eliminations of catheter–related bloodstream infections- An APIC guide 2009.
28.
Getting Started Kit: Prevent Central Line Infections, Central Line Associated - Blood Stream Infections (CLA-BSI) Safer Healthcare Now! Campaign (SHN) 2009
29.
Central line insertion and maintenance guidelines. Australian Commission on Safety and Quality in Health care 2012.
30.
Camp-Sorrell D, editor. Access Device Guidelines: Recommendations for Nursing Practice and Education. 3rd ed. Pittsburgh: Oncology Nursing Society; 2011. Copyright 2011 by ONS. INS 2011 Infusion Nursing Standards of Practice.
31.
Basic Infection Control And Prevention Plan for Outpatient Oncology Settings CDC December 2011
32.
Guide to the Elimination of Infections in Hemodialysis, An APIC Guide 2010
33.
NHMRC Australian Guidelines for the Prevention and Control of Infection in Healthcare. Commonwealth of Australia 2010.
34.
35.
36.
Guide H-t. Prevent Central Line-Associated Bloodstream Infections. Cambridge: Institute for Healthcare Improvement; 2012.
37.
Weaver SJ, Lubomksi LH, Wilson RF, Pfoh ER, Martinez KA, Dy SM. Promoting a culture of safety as a patient safety strategy: a systematic review. Ann Intern Med. 2013;158(5 pt 2):369–74.CrossRefPubMedPubMedCentral
38.
Hatler CW, Mast D, Corderella J, et al. Using evidence and process improvement strategies to enhance healthcare outcomes for the critically ill: a pilot project. Am J Crit Care. 2006;15(6):549–55.PubMed
39.
Warye KL, Murphy DM. Targeting zero health care–associated infections. Am J Infect Control. 2008;36:683–4.CrossRefPubMed
40.
Gilbert GL, Cheung PY, Kerridge IB. Infection control, ethics and accountability. Med J Aust. 2009;190(12):696–8.PubMed
41.
Marschall J, Mermel LA, Fakih M, et al. Strategies to Prevent Central Line–Associated Bloodstream Infections in Acute Care Hospitals: 2014 Update. Infect Control Hosp Epidemiol. 2014;35(7):753–71.CrossRefPubMed
42.
Garland JS, Alex CP, Mueller CD, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics. 2001;107(6):1431–6.CrossRefPubMed
43.
Spencer C, Orr D, Hallam S, Tillmanns E. Daily bathing with octenidine on an intensive care unit is associated with a lower carriage rate of meticillin-resistant Staphylococcus aureus. J Hosp Infect. 2013;83(2):156–9.CrossRefPubMed
44.
Timsit JF, Schwebel C, Bouadma L, Geffroy A, Garrouste-Orgeas M, Pease S, Herault MC, Haouache H, Calvino-Gunther S, Gestin B. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA. 2009;301:1231–41.CrossRefPubMed
45.
Tamma PD, Aucott SW, Milstone AM. Chlorhexidine use in the neonatal intensive care unit: results from a national survey. Infect Control Hosp Epidemiol. 2010;31(8):846–9.CrossRefPubMedPubMedCentral
46.
Huang EY, Chen C, Abdullah F, et al. Strategies for the prevention of central venous catheter infections: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg. 2011;46(10):2000–2011.CrossRefPubMed
47.
O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S. Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162–93. Epub 2011 Apr 1.CrossRefPubMedPubMedCentral
48.
Batra R, Cooper BS, Whiteley C, Patel AK, Wyncoll D, Edgeworth JD. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis. 2010;50(2):210–7.CrossRefPubMed
49.
Lai NM, Chaiyakunapruk N, Lai NA, O’Riordan E, Pau WS, Saint S. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. Cochrane Database Syst Rev. 2013;6:CD007878.PubMed
50.
Hagau N, Studnicska D, Gavrus RL, Csipak G, Hagau R, Slavcovici AV. Central venous catheter colonization and catheter-related bloodstream infections in critically ill patients: a comparison between standard and silver-integrated catheters. Eur J Anaesthesiol. 2009;26:752–8.CrossRefPubMed
51.
Antonelli M, De Pascale G, Ranieri VM, Pelaia P, Tufano R, Piazza O, et al. Comparison of triple-lumen central venous catheters impregnated with silver nanoparticles (AgTive(R)) vs conventional catheters in intensive care unit patients. J Hosp Infect. 2012;82:101–7.CrossRefPubMed
52.
Weber JM, Sheridan RL, Fagan S, Ryan CM, Pasternack MS, Tompkins RG. Incidence of catheter-associated bloodstream infection after introduction of minocycline and rifampin antimicrobial-coated catheters in a pediatric burn population. J Burn Care Res. 2012;33:539–43.CrossRefPubMed
53.
Chelliah A, Heydon KH, Zaoutis TE, Rettig SL, Dominguez TE, Lin R, et al. Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients. Pediatr Infect Dis J. 2007;26:816–20.CrossRefPubMed
54.
Bertini G, Elia S, Ceciarini F, Dani C. Reduction of catheter-related bloodstream infections in preterm infants by the use of catheters with the AgION antimicrobial system. Early Hum Dev. 2013;89:21–5.CrossRefPubMed
55.
Zhao Y, Li Z, Zhang L, Yang J, Yang Y, Tang Y, et al. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials. Am J Kidney Dis. 2014;63:479–90.CrossRefPubMed
56.
Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis. 2008;47:83–93.CrossRefPubMed
57.
Jaffer Y, Selby NM, Taal MW, Fluck RJ, McIntyre CW. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis. 2008;51:233–41.CrossRefPubMed
58.
Labriola L, Crott R, Jadoul M. Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. Nephrol Dial Transplant. 2008;23:1666–72.CrossRefPubMed
59.
Snaterse M, Ruger W, Scholte Op Reimer WJ, Lucas C. Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. J Hosp Infect. 2010;75:1–11.CrossRefPubMed
60.
Zacharioudakis IM, Zervou FN, Arvanitis M, Ziakas PD, Mermel LA, Mylonakis E. Antimicrobial lock solutions as a method to prevent central line-associated bloodstream infections: a meta-analysis of randomized controlled trials. Clin Infect Dis. 2014. doi:10.​1093/​cid/​ciu671.
61.
van de Wetering MD, van Woensel JB, Lawrie TA. Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients. Cochrane Database Syst Rev. 2013;11:CD003295.PubMed
62.
Catheter WM. Llubrication and fixation: interventions. Br J Nurs. 2013;22(10):566. 568-9.CrossRef
63.
Alekseyev S, Byrne M, Carpenter A, Franker C, Kidd C, Hulton L. Prolonging the life of a patient’s IV: an integrative review of intravenous securement devices. Medsurg Nurs. 2012;21(5):285–92.PubMed
64.
Petree C, Wright DL, Sanders V, Killion JB. Reducing blood stream infections during catheter insertion. Radiol Technol. 2012;83(6):532–40.PubMed
65.
Cotogni P, Pittiruti M, Barbero C, Monge T, Palmo A, Boggio Bertinet D. Catheter-related complications in cancer patients on home parenteral nutrition: a prospective study of over 51,000 catheter days. JPEN J Parenter Enteral Nutr. 2013;37(3):375–83.CrossRefPubMed
66.
Christopher C, Maki DG. The Promise of Novel Technology for the Prevention of Intravascular Device–Related Bloodstream Infection. Clin Infect Dis. 2002;34(10):1362–8. Epub 2002 Apr 17.CrossRef
67.
Simonova G, Rickard CM, Dunster KR, Smyth DJ, McMillan D, Fraser JF. Cyanoacrylate tissue adhesives - effective securement technique for intravascular catheters: in vitro testing of safety and feasibility. Anaesth Intensive Care. 2012;40(3):460–6.PubMed
68.
Egan GM, Siskin GP, Weinmann 4th R, Galloway MM. A prospective postmarket study to evaluate the safety and efficacy of a new peripherally inserted central catheter stabilization system. J Infus Nurs. 2013;36(3):181–8.CrossRefPubMed
69.
Sundararajan K, Wills S, Chacko B, Kanabar G, O’Connor S, Deane A. Impact of delirium and suture-less securement on accidental vascular catheter removal in the ICU. Anaesth Intensive Care. 2014;42(4):473–9.PubMed
70.
Rupp ME, Sholtz LA, Jourdan DR, et al. Outbreak of bloodstream infection temporally associated with the use of an intravascular needleless valve. Clin Infect Dis. 2007;44:1408–14.CrossRefPubMed
71.
Maragakis LL, Bradley KL, Song X, et al. Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infect Control Hosp Epidemiol. 2006;27(1):67–70.CrossRefPubMed
72.
Mazher MA, Kallen A, Edwards JR, Donlan RM. An in vitro evaluation of disinfection protocols used for needleless connectors of central venous catheters. Lett Appl Microbiol. 2013;57(4):282–7. doi:10.​1111/​lam.​12108. Epub 2013 Jun 7.PubMed
73.
74.
75.
Menyhay SZ, Maki DG. Preventing central venous catheter-associated bloodstream infections: development of an antiseptic barrier cap for needleless connectors. Am J Infect Control. 2008;36(10):S174. doi:10.​1016/​j.​ajic.​2008.​10.​006. e1-5.PubMed
76.
Sweet MA, Cumpston A, Briggs F, Craig M, Hamadani M. Impact of alcohol-impregnated port protectors and needleless neutral pressure connectors on central line-associated bloodstream infections and contamination of blood cultures in an inpatient oncology unit. Am J Infect Control. 2012;40(10):931–4. doi:10.​1016/​j.​ajic.​2012.​01.​025. Epub 2012 May 9.CrossRefPubMed
77.
78.
Ling ML, Apisarnthanarak A, Madriaga G. The burden of healthcare-associated infections in Southeast Asia: A systematic literature review and meta-analysis. Clinical Infectious Diseases 2015: civ095v1-civ095
Metadata
Title
APSIC guide for prevention of Central Line Associated Bloodstream Infections (CLABSI)
Authors
Moi Lin Ling
Anucha Apisarnthanarak
Namita Jaggi
Glenys Harrington
Keita Morikane
Le Thi Anh Thu
Patricia Ching
Victoria Villanueva
Zhiyong Zong
Jae Sim Jeong
Chun-Ming Lee
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2016
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-016-0116-5

Other articles of this Issue 1/2016

Antimicrobial Resistance & Infection Control 1/2016 Go to the issue

Research

Cross-border comparison of antibiotic prescriptions among children and adolescents between the north of the Netherlands and the north-west of Germany

Short report

Emergence of serotype K1 Klebsiella pneumoniae ST23 strains co-producing the plasmid-mediated AmpC beta-lactamase DHA-1 and an extended-spectrum beta-lactamase in Korea

Research

Serious electronic games as behavioural change interventions in healthcare-associated infections and infection prevention and control: a scoping review of the literature and future directions

Research

Prolonged outbreak of clonal MDR Pseudomonas aeruginosa on an intensive care unit: contaminated sinks and contamination of ultra-filtrate bags as possible route of transmission?

Research

Poor adherence to guidelines for preventing central line-associated bloodstream infections (CLABSI): results of a worldwide survey

Research

Identifying conditions for elimination and epidemic potential of methicillin-resistant Staphylococcus aureus in nursing homes

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits